ACM
CELG

Arlington Capital Management’s Celgene Corp CELG Stock Holding History

Arlington Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-31,287
Closed -$3.66M – 36
2015
Q2 		$3.66M Buy
31,287
+2,718
+10% +$311K 2.45% 12
2015
Q1 		$3.29M Buy
28,569
+2,741
+11% +$328K 2.36% 13
2014
Q4 		$2.89M Buy
+25,828
New +$2.72M 2.44% 11

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Arlington Capital Management's CELG Position: Q3 2015 in Review

Arlington Capital Management sold out of Celgene Corp (CELG) in Q3 2015, closing a stake of 31,287 shares — an estimated $3.66M sold.

Arlington Capital Management first reported a position in CELG in Q4 2014 and held it in 3 quarters. The position peaked at $3.66M in Q2 2015. 1,195 funds tracked by Wall St. Rank hold CELG as of Q3 2015.

  • Arlington Capital Management reported no remaining Celgene Corp position as of Q3 2015 after selling out during the quarter.
  • Arlington Capital Management sold 31,287 Celgene Corp shares in Q3 2015, an estimated $3.66M.
  • Arlington Capital Management first reported a position in Celgene Corp in Q4 2014 and held it in 3 quarters.
  • Arlington Capital Management's Celgene Corp position peaked at $3.66M in Q2 2015.
  • 1,195 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2015.

Based on Arlington Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.